DOCSLIB.ORG

New Trends in Street Drugs Upon Completion of This Program the Learner Will Be Able To

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
New Trends in Street Drugs Upon Completion of This Program the Learner Will Be Able To Objectives New Trends in Street Drugs Upon completion of this program the learner will be able to: th September 14 , 2015 1. Identify new trends in street drug use and legal Rochester, New York highs 2. Discuss some of the geographic, demographic and Dr. Andrea Efre cultural factors of drug use DNP, ARNP, ANP-BC, FNP-C 3. Review signs, symptoms and treatment options of Nurse Practitioner suspected drug use, withdrawal or overdose and Professor in Graduate Nursing NIH: Monitoring the Future 2014 New Trends in Street Drugs National Trends: Prescription drugs are still a problem but turning to Heroin as an alternative Cocaine, Meth and Heroin are regional Hallucinogenic: LSD (Acid) and MDMA (Ecstasy, Molly) Methamphetamine – Regional Marijuana use and dependence has risen (plus introduction of Wax/Dabs) Daily use of Synthetic cannabinoids (K2 and Spice) Marijuana remains Synthetic Cathinones (Bath Salts, Flakka) common Chemical Drugs – EG: 2C-I, N-Bomb, B-Fly, Internet Purchases – “Legal Highs” Old Drug – New Trends… Rochester Trends Heroin Heroin: May be smoked snorted or injected Dr. Jeremy Cushman, Recently used as an alternative to Rx drugs Monroe County Interim Health Commissioner: Cutting Heroin: When other substances are used to increase the bulk: There were 94 heroin- • Talcum powder related deaths in 2014 (triple that of 2012) • Dextrose • Flour • Mannitol More than 180 doses of Naloxone were given in last year to reverse heroin overdose 1 Symptoms of Heroin Use Long Term Effects of Heroin Pulmonary complications - Including pneumonia Short Term Effects Organ complications (including Liver disease) and vessel damage due to the additives that the heroin Confusion, Disorientation, Delirium was cut with Cold and clammy skin “Rush” feeling a surge of euphoria Needle Users Long Term Effects Endocarditis Accompanied by a warm flushing of the skin Collapsed veins Dry mouth, and heavy extremities Abscesses Cellulites “On the Nod" following the initial euphoria, this is a wakeful and drowsy state Infected sites HIV, Hep B and C in needle users Signs of Overdose Withdrawal Opioid OD triad (observed in Heroin and opiates) Drug craving Coma Restlessness, Insomnia Respiratory depression and failure Muscle and bone pain Vomiting and diarrhea Depression of CNS – Miosis - pin point pupils Cold flashes with Piloerection (goose bumps know as Convulsions (Seizures) "cold turkey") Hypoxia and Cynosis Kicking movements ("kicking the habit") Hypotension Withdrawal symptoms peak between 48 and 72 hours and subside after about a week. Bradycardia Sudden withdrawal by heavily dependent users in poor Respiratory depression – Prepare to intubate health is occasionally fatal (less dangerous than alcohol or barbiturate withdrawal) If found in community: Call 911 - Must go to ER – Even if Naloxone (Narcan) given (short 1/2 life) Use in pregnancy leads to Neonatal abstinence Syndrome (NAS) in the baby Krokodil Krokodil “Krokodil,” a toxic homemade opioid Made by combining codeine tablets with The flesh destroyed by krokodil various toxic chemicals including lighter becomes gangrenous, and, in fluid and industrial cleaners some cases, limb amputation has been necessary to save a Used as cheap heroin substitute in poor rural areas of Russia – user’s life. In 2011, it was estimated that as many as 2 million Russians Users often present with were addicted multiple scabs and skin Has similar effects in the brain as heroin, but more powerful infections. and has a shorter duration. Users often smell of iodine Spread into Europe - Germany, France, Belgium, Sweden, Krokodil gets its name from Norway, Czech Republic, and Ukraine the scaly, gray-green dead Has recently been featured in news reports alleging its skin that forms at the site of appearance in parts of the United States an injection. Case reported in St. Louis - (Thekkemuriyi, John, & Pillai, 2014) 2 Krokodil 2015 Drug Trends: Cocaine Cocaine Powder Crack Cocaine Cocaine is a White All you need is: crystalline powder • Cocaine, Baking Soda, Freely soluble in water Water, Heat Popular method: ‘Free' the cocaine “Snort" lines with a alkaloid 'base' from the straw, rolled up paper salt U.S., many are hoping that the or $ bill pictures of flesh rotting off the No salt = combustion = bone like the following will be Smoke enough to discourage any potential Not soluble Krokodil users from ever trying this devastating drug. Intense high lasts 5-30 mins Signs of Overdose of Cocaine Medications and Cocaine Treatments: Tachycardia and Hypertension Arrhythmias, Widened QRS/Q and prolonged QT segment Charcoal - Oral ingestion (especially stuffers/packers) MI/ ACS/ Coronary artery spasms that cause MI Benzodiazepines and vasodilators for HTN (nitroprusside and NTG) V-Fib/Cardiac arrest (High doses) Ventricular arrhythmias may respond to sodium bicarbonate (effects of cocaine on the Na+ Channels), lidocaine (in combo Tremors, hallucinations and delirium with Benzodiazapines) and Magnesium Agitated (excited) delirium Medications to Avoid: Seizures and convulsions Avoid Beta-blockers - unopposed alpha responses (BP, Hyperthermia (Dopaminergic regulation of core temperature) Coronary blood flow, CO) Rhabdomyolysis (from Dopaminergic changes) Avoid Calcium Channel blockers ( ingested cocaine from GI, Respiratory arrest and may ICP). Avoid Nifedipine (Procardia, Adalat) seizures Aortic Dissection Avoid some antiarrhythmics: quinidine, procainamide, and disopyramide (Norpace) (class 1a) > QRS and QT intervals and Emboli may occur from injection slows the metabolism of cocaine Methamphetamine What does Meth look like? . A white odorless powder that easily dissolves in water or alcohol and bitter- tasting Street terms are: Speed Black Beauties Meth Tweak Poor man’s Cocaine Glass Crystal meth Ice Crystal Amphetamines Chalk Bikers Coffee Crank Yaba (pills) Uppers Yellow Bam Use/Route: Oral, Snorting, Smoking , IV or Rectal (Bootie bump) 3 Short Term Long Term Signs of Overdose of Effects Effects Methamphetamine Smoking or IV provides an intense sensation, called a Skin abscesses appear as Symptoms of use and signs of overdose are very “rush” or “flash,” chemicals rise to the surface similar to cocaine and Teeth rot from gum line Lasts only a few minutes and is Hyperthermia described as extreme pleasure Acute lead poisoning is a potential risk for Convulsions/seizures Oral, intranasal or rectal use methamphetamine abusers Produces euphoria - a high, but Risk of Parkinson's and Anxiety, confusion, depression not a rush alzheimers Chronic fatigue, insomnia Heart failure Delusions, paranoia, aggression, hallucinations Brain damage Stroke Toxic psychosis Epilepsy Treatment discussed later Street terms: 3,4 Methylenedioxymethylamphetamine, (MDMA) Ecstasy (pill) Invented in 1912 for medicine, Patented by Merck 1914 Molly (powder) In the 1970’s, it was used in psychotherapy Also known as: Mid 1980’s used as a street and illicit drug XTC, X Schedule I drug with no current acceptable medical use Adam MDMA tablets are usually sold with logos, creating brand Hug drug names for users to seek out MDMA or MDA Dove Colorful pills may be hidden among colorful candies Love, E Molly - MDMA Molly—slang for “molecular” How is MDMA Used? Usually contains Pure MDMA Can be snorted, injected, and rectally inserted, but is usually taken orally in tablet form Ecstasy often has additives such as caffeine or Methamphetamine Effects last approximately 4 to 6 hours Pure crystalline powder, or can Considered a “party drug.” be capsules containing powder Rarely used alone, Commonly mixed with alcohol and Molly = street term to describe some “Bathsalts” such as marijuana Methylone: (bk-MDMA) or Mephodrone (meow meow) “Candy flipping” is the combination of MDMA and LSD (especially in the UK) “Stacking” is taking three MDMA or more tablets at once Molly = street term for Methampetamine/meth combos “Piggy-backing” is taking a series of tablets over a short User may not get what they expected with Molly period of time 4 Molly - MDMA Molly can be purchased in capsules for $8 to Uses (why people use) $40 per pill depending on location Molly had a surge in interest in the past few MDMA in any form Reduces inhibitions years, being celebrated frequently by actors produces energy and euphoria Produces feelings of and musicians empathy/affection for others Suppresses the need to Molly also comes in the form of high-priced, eat, drink, or sleep Talking excessively specially branded water, called Mollywatr (glow-in-the-dark container). Enables club-scene users Enjoying touching to endure all-night / 2-3 day parties Enjoying being touched Eliminates anxiety Making it a Rape Drug Giggling uncontrollably Side Effects Side Effects: Overheated/Increased core temperature Jaw muscle tension Dry mouth Hyperthermia 107-109°F Teeth grinding and Dilated pupils involuntary clenching Blurred vision Loss of consciousness Users will often suck on Seizures pacifiers and candy to Nausea help relieve the tension Faintness Confusion & Panic attacks Muscle tension Chills/Sweating Tachycardia Tremors Problems sleeping Hypertension Muscle cramps Depression Hepatic/Renal failure Twitching Dehydration is common Death Lysergic Acid Diethylamide (LSD) Signs of Use/Side Effects of LSD Street terms: "acid”, Dots, Mellow Yellow, Elevated BP Flashbacks are a Loony toons, Blotter Tachycardia, Palpitations unpredictable and First discovered in 1938 dangerous side effect Produced in the US - on the West Coast, Hyperthermia particularly San Francisco Elevated blood sugar Occur spontaneously
Load more

Recommended publications
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Hallucinogens - LSD, Peyote, Psilocybin, and PCP Hallucinogenic compounds found in some • Psilocybin (4-phosphoryloxy-N,N- plants and mushrooms (or their extracts) dimethyltryptamine) is obtained from have been used—mostly during religious certain types of mushrooms that are rituals—for centuries. Almost all indigenous to tropical and subtropical hallucinogens contain nitrogen and are regions of South America, Mexico, and classified as alkaloids. Many hallucinogens the United States. These mushrooms have chemical structures similar to those of typically contain less than 0.5 percent natural neurotransmitters (e.g., psilocybin plus trace amounts of acetylcholine-, serotonin-, or catecholamine- psilocin, another hallucinogenic like). While the exact mechanisms by which substance. hallucinogens exert their effects remain • PCP (phencyclidine) was developed in unclear, research suggests that these drugs the 1950s as an intravenous anesthetic. work, at least partially, by temporarily Its use has since been discontinued due interfering with neurotransmitter action or to serious adverse effects. by binding to their receptor sites. This DrugFacts will discuss four common types of How Are Hallucinogens Abused? hallucinogens: The very same characteristics that led to • LSD (d-lysergic acid diethylamide) is the incorporation of hallucinogens into one of the most potent mood-changing ritualistic or spiritual traditions have also chemicals. It was discovered in 1938 led to their propagation as drugs of abuse. and is manufactured from lysergic acid, Importantly, and unlike most other drugs, which is found in ergot, a fungus that the effects of hallucinogens are highly grows on rye and other grains. variable and unreliable, producing different • Peyote is a small, spineless cactus in effects in different people at different times.
    [Show full text]
  • Hallucinogens - LSD, Peyote, Psilocybin, and PCP
    Information for Behavioral Health Providers in Primary Care Hallucinogens - LSD, Peyote, Psilocybin, and PCP What are Hallucinogens? Hallucinogenic compounds found in some plants and mushrooms (or their extracts) have been used— mostly during religious rituals—for centuries. Almost all hallucinogens contain nitrogen and are classified as alkaloids. Many hallucinogens have chemical structures similar to those of natural neurotransmitters (e.g., acetylcholine-, serotonin-, or catecholamine-like). While the exact mechanisms by which hallucinogens exert their effects remain unclear, research suggests that these drugs work, at least partially, by temporarily interfering with neurotransmitter action or by binding to their receptor sites. This InfoFacts will discuss four common types of hallucinogens: LSD (d-lysergic acid diethylamide) is one of the most potent mood-changing chemicals. It was discovered in 1938 and is manufactured from lysergic acid, which is found in ergot, a fungus that grows on rye and other grains. Peyote is a small, spineless cactus in which the principal active ingredient is mescaline. This plant has been used by natives in northern Mexico and the southwestern United States as a part of religious ceremonies. Mescaline can also be produced through chemical synthesis. Psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) is obtained from certain types of mushrooms that are indigenous to tropical and subtropical regions of South America, Mexico, and the United States. These mushrooms typically contain less than 0.5 percent psilocybin plus trace amounts of psilocin, another hallucinogenic substance. PCP (phencyclidine) was developed in the 1950s as an intravenous anesthetic. Its use has since been discontinued due to serious adverse effects. How Are Hallucinogens Abused? The very same characteristics that led to the incorporation of hallucinogens into ritualistic or spiritual traditions have also led to their propagation as drugs of abuse.
    [Show full text]
  • Hallucinogens and Dissociative Drugs
    Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs — which have street names like acid, angel dust, and vitamin K — distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD, psilocybin, peyote, DMT, and ayahuasca cause HALLUCINOGENS AND emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, DISSOCIATIVE DRUGS ketamine, dextromethorphan, and Salvia divinorum may make a user feel out of Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, control and disconnected from their body PCP, Ketamine, Dextromethorphan, and Salvia and environment. In addition to their short-term effects What Are on perception and mood, hallucinogenic Hallucinogens and drugs are associated with psychotic- like episodes that can occur long after Dissociative Drugs? a person has taken the drug, and dissociative drugs can cause respiratory allucinogens are a class of drugs that cause hallucinations—profound distortions depression, heart rate abnormalities, and in a person’s perceptions of reality. Hallucinogens can be found in some plants and a withdrawal syndrome. The good news is mushrooms (or their extracts) or can be man-made, and they are commonly divided that use of hallucinogenic and dissociative Hinto two broad categories: classic hallucinogens (such as LSD) and dissociative drugs (such drugs among U.S. high school students, as PCP). When under the influence of either type of drug, people often report rapid, intense in general, has remained relatively low in emotional swings and seeing images, hearing sounds, and feeling sensations that seem real recent years.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • Federal Register/Vol. 85, No. 178/Monday, September 14, 2020
    Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices 56631 agreements. All non-confidential DEPARTMENT OF JUSTICE ADDRESSES: Written comments should written submissions will be available for be sent to: Drug Enforcement public inspection at the Office of the Drug Enforcement Administration Administration, Attention: DEA Federal Secretary and on EDIS. [Docket No. DEA–713] Register Representative/DPW, 8701 The Commission vote for these Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must determinations took place on September Importer of Controlled Substances Application: Cerilliant Corporation be sent to: Drug Enforcement 8, 2020. Administration, Attn: Administrator, The authority for the Commission’s AGENCY: Drug Enforcement 8701 Morrissette Drive, Springfield, determination is contained in section Administration, Justice. Virginia 22152. All request for a hearing 337 of the Tariff Act of 1930, as ACTION: Notice of application. should also be sent to: (1) Drug amended (19 U.S.C. 1337), and in Part SUMMARY: Cerilliant Corporation has Enforcement Administration, Attn: 210 of the Commission’s Rules of applied to be registered as an importer Hearing Clerk/OALJ, 8701 Morrissette Practice and Procedure (19 CFR part of basic class(es) of controlled Drive, Springfield, Virginia 22152; and 210). substance(s). Refer to Supplemental (2) Drug Enforcement Administration, Attn: DEA Federal Register By order of the Commission. Information listed below for further Representative/DPW, 8701 Morrissette Issued: September 8, 2020. drug information. DATES: Drive, Springfield, Virginia 22152. Lisa Barton, Registered bulk manufacturers of the affected basic class(es), and SUPPLEMENTARY INFORMATION: In Secretary to the Commission. applicants therefore, may file written accordance with 21 CFR 1301.34(a), this [FR Doc.
    [Show full text]
  • Synthetic Drugs: Overview and Issues for Congress
    Synthetic Drugs: Overview and Issues for Congress Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy Kristin Finklea Specialist in Domestic Security May 3, 2016 Congressional Research Service 7-5700 www.crs.gov R42066 Synthetic Drugs: Overview and Issues for Congress Summary Synthetic drugs, as opposed to natural drugs, are chemically produced in a laboratory. Their chemical structure can be either identical to or different from naturally occurring drugs, and their effects are designed to mimic or even enhance those of natural drugs. When produced clandestinely, they are not typically controlled pharmaceutical substances intended for legitimate medical use. Designer drugs are a form of synthetic drugs. They contain slightly modified molecular structures of illegal or controlled substances, and they are modified in order to circumvent existing drug laws. While the issue of synthetic drugs and their abuse is not new, Congress has demonstrated a renewed concern with the issue. From 2009 to 2011, synthetic drug abuse was reported to have dramatically increased. During this time period, calls to poison control centers for incidents relating to harmful effects of synthetic cannabinoids (such as “K2” and “Spice”) and stimulants (such as “bath salts”) increased at what some considered to be an alarming rate. The number of hospital emergency department visits involving synthetic cannabinoids more than doubled from 2010 to 2011. In 2012 and 2013, however, the number of calls to poison control centers for incidents relating to harmful effects of synthetic cannabinoids and synthetic stimulants decreased. Calls regarding bath salts have declined each year since 2011, while calls regarding synthetic cannabinoids have increased since the drops in 2012 and 2013.
    [Show full text]
  • ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
    The ASAM NATIONAL The ASAM National Practice Guideline 2020 Focused Update Guideline 2020 Focused National Practice The ASAM PRACTICE GUIDELINE For the Treatment of Opioid Use Disorder 2020 Focused Update Adopted by the ASAM Board of Directors December 18, 2019. © Copyright 2020. American Society of Addiction Medicine, Inc. All rights reserved. Permission to make digital or hard copies of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for commercial, advertising or promotional purposes, and that copies bear this notice and the full citation on the fi rst page. Republication, systematic reproduction, posting in electronic form on servers, redistribution to lists, or other uses of this material, require prior specifi c written permission or license from the Society. American Society of Addiction Medicine 11400 Rockville Pike, Suite 200 Rockville, MD 20852 Phone: (301) 656-3920 Fax (301) 656-3815 E-mail: [email protected] www.asam.org CLINICAL PRACTICE GUIDELINE The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update 2020 Focused Update Guideline Committee members Kyle Kampman, MD, Chair (alpha order): Daniel Langleben, MD Chinazo Cunningham, MD, MS, FASAM Ben Nordstrom, MD, PhD Mark J. Edlund, MD, PhD David Oslin, MD Marc Fishman, MD, DFASAM George Woody, MD Adam J. Gordon, MD, MPH, FACP, DFASAM Tricia Wright, MD, MS Hendre´e E. Jones, PhD Stephen Wyatt, DO Kyle M. Kampman, MD, FASAM, Chair 2015 ASAM Quality Improvement Council (alpha order): Daniel Langleben, MD John Femino, MD, FASAM Marjorie Meyer, MD Margaret Jarvis, MD, FASAM, Chair Sandra Springer, MD, FASAM Margaret Kotz, DO, FASAM George Woody, MD Sandrine Pirard, MD, MPH, PhD Tricia E.
    [Show full text]
  • Immediate Action New Tests and Test Updates
    Effective Date: Monday, August 26, 2013 New Tests and Test Updates Immediate Action In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the types of changes that may be included in this notification, effective Monday, August 26, 2013 New Tests - Tests recently added to the NMS Labs test menu. New Tests are effective immediately. Test Changes - Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements. Discontinued Tests - Tests being discontinued with alternate testing suggestions. Please use this information to update your computer systems/records. These changes are important to ensure standardization of our mutual laboratory databases. If you have any questions about the information contained in this notification, please call our Client Support Department at (866) 522-2206. Thank you for your continued support of NMS Labs and your assistance in implementing these changes. The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. NMS Labs does not assume responsibility for billing errors due to reliance on the CPT Codes listed in this document. NMS LABS 3701 Welsh Road Willow Grove, PA 19090 www.NMSLabs.com Page 1 of 76 Effective Date: Monday, August 26, 2013 New Tests and Test Updates Test Test Name New Test Method / Specimen Stability Scope Units Reference Discontinue
    [Show full text]
  • SUBLOCADE Education Brochure | SUBLOCADE® (Buprenorphine Extended-Release) Injection, for Subcutaneous Use (CIII) KEEP MOVING TOWARDS RECOVERY with Once-Monthly
    SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue or inside the cheek) buprenorphine-containing medicine at a dose that controls withdrawal symptoms for at least 7 days. SUBLOCADE is part of a complete treatment plan that should include counseling. SUBLOCADE Education Brochure | SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) KEEP MOVING TOWARDS RECOVERY with once-monthly Individuals depicted are models used for illustrative purposes only. IMPORTANT SAFETY INFORMATION Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program. • SUBLOCADE is not available in retail pharmacies. • Your SUBLOCADE injection will only be given to you by a certified healthcare provider. Please see SUBLOCADE full Prescribing Information including BOXED WARNING and Medication Guide at sublocade.com, or included in the back of this brochure. Opioid addiction may be an overwhelming problem. But don’t give up. There are different ways to tackle it. Living with opioid addiction can be a struggle. But it’s important Opioid addiction is actually a disease called Opioid Use Disorder Medication-assisted treatment (MAT), which combines to understand that even when someone tries again and again (OUD), and it involves compulsive drug seeking and use, despite medication and counseling, is an option that can help manage to quit, it’s not a sign of weakness or failure.
    [Show full text]
  • Ecstasy and Club Drugs
    Ecstasy and Club Drugs The term “club drug” refers to drugs being used by youth and young adults at all-night dance parties such as “raves” or “trances,” dance clubs and bars. MDMA (Ecstasy), GHB, Rohypnol, Ketamine, Methamphetamine, and LSD are among the drugs referred to as “club drugs.” “Raves” are a form of dance and recreation that is held in a clandestine location with fast-paced, high-volume music, a variety of high-tech entertainment and usually the use of “club drugs.” Ecstasy Ecstasy or MDMA (methylenedioxymethamphetamine) is a stimulant that combines the properties of methamphetamine or “speed” with mind-altering or hallucinogenic properties. It is considered to be the most commonly used club (or “designer” drug). Ecstasy is an illegal drug (it was declared illegal by the federal government in 1985) 90% of which is manufactured in the Netherlands and Belgium. In its most common form, Ecstasy is a small tablet that is impressed with any one of a number of logos intended to attract young people. It can also be in capsule or powder form and can be injected. Among the street names for Ecstasy are Adam, X-TC, Clarity, Essence, Stacy, Lover’s Speed, Eve, etc. The Ecstasy high can last from 6 to 24 hours, with the average “trip” lasting only about 3-4 hours. Users of Ecstasy report that it causes mood changed and loosens their inhibitions; they become more outgoing, empathetic and affectionate. For this reason, Ecstasy has been called the “hug drug.” It also suppresses the need to eat, drink or sleep, enabling users to endure parties that can last for two or three days.
    [Show full text]
  • Active Constituents Identification Chart (May 2010, Pre-Ban)
    Head Shop ‘Legal Highs’ Active Constituents Identification Chart (May 2010, pre-ban) •Mephedrone •Mephedrone •Mephedrone •Mephedrone •Methylone •Methylone •Methylone (66.1% as HCl salt, (82.2% as HCl salt, (14.6% as HCl salt, (39.9% as HCl salt, 54.8% as free base) 68.1% as free base ) 12.1% as free base) 33.1% as free base) •Caffeine •Benzocaine •Benzocaine •Methylone •Mephedrone •Flephedrone •Flephedrone •MDPV •Caffeine •MDPV •Lignocaine •Lignocaine •Dimethylamylamine (DMAA) •Caffeine •Caffeine Pack 1 Pack 2 •Flephedrone •MDPV •MDPV •MDPV •Butylone •Butylone •Lignocaine •Lignocaine •Lignocaine •A significant amount of what is believed •MDPV •Caffeine to be an isomer of butylone was also found. •p-Fluorophenylpiperazine •Butylone •m-Trifluoromethylphenylpiperazine •Caffeine (100 %) •Butylone •Dimethylamylamine (DMAA) (pPFP) •Caffeine (mTFMPP) •2-Phenylethylamine (2-PEA) •Caffeine •Caffeine •Hordenine •Caffeine •Methylone •m-Trifluoromethylphenylpiperazine •Mephedrone •2-Aminoindane (2-AI, •MDPV (mTFMPP) 2-indanamine) •1-MthlMethyl-4-bliibenzylpiperazine (MthlMethyl BZP) •CffiCaffeine •Caffeine •m-Trifluoromethylphenylpiperazine •Caffeine (99 %) •Butylone •Butylone (mTFMPP) •MDPV •Mephedrone •p-Fluorophenylpiperazine (pPFP) •Caffeine •Butylone •Mephedrone •2-Phenylethylamine (2-PEA) •Caffeine •Dimethylamylamine (DMAA) •Lignocaine •Dime thy lamy lam ine (DMAA) •Dime thy lamy lam ine (DMAA) •Caffeine These are the active constituents that we have found to date in the above products. It may be expected that Next Generation Compounds (NGC's)
    [Show full text]
  • Appendix D: Important Facts About Alcohol and Drugs
    APPENDICES APPENDIX D. IMPORTANT FACTS ABOUT ALCOHOL AND DRUGS Appendix D outlines important facts about the following substances: $ Alcohol $ Cocaine $ GHB (gamma-hydroxybutyric acid) $ Heroin $ Inhalants $ Ketamine $ LSD (lysergic acid diethylamide) $ Marijuana (Cannabis) $ MDMA (Ecstasy) $ Mescaline (Peyote) $ Methamphetamine $ Over-the-counter Cough/Cold Medicines (Dextromethorphan or DXM) $ PCP (Phencyclidine) $ Prescription Opioids $ Prescription Sedatives (Tranquilizers, Depressants) $ Prescription Stimulants $ Psilocybin $ Rohypnol® (Flunitrazepam) $ Salvia $ Steroids (Anabolic) $ Synthetic Cannabinoids (“K2”/”Spice”) $ Synthetic Cathinones (“Bath Salts”) PAGE | 53 Sources cited in this Appendix are: $ Drug Enforcement Administration’s Drug Facts Sheets1 $ Inhalant Addiction Treatment’s Dangers of Mixing Inhalants with Alcohol and Other Drugs2 $ National Institute on Alcohol Abuse and Alcoholism’s (NIAAA’s) Alcohol’s Effects on the Body3 $ National Institute on Drug Abuse’s (NIDA’s) Commonly Abused Drugs4 $ NIDA’s Treatment for Alcohol Problems: Finding and Getting Help5 $ National Institutes of Health (NIH) National Library of Medicine’s Alcohol Withdrawal6 $ Rohypnol® Abuse Treatment FAQs7 $ Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Keeping Youth Drug Free8 $ SAMHSA’s Center for Behavioral Health Statistics and Quality’s (CBHSQ’s) Results from the 2015 National Survey on Drug Use and Health: Detailed Tables9 The substances that are considered controlled substances under the Controlled Substances Act (CSA) are divided into five schedules. An updated and complete list of the schedules is published annually in Title 21 Code of Federal Regulations (C.F.R.) §§ 1308.11 through 1308.15.10 Substances are placed in their respective schedules based on whether they have a currently accepted medical use in treatment in the United States, their relative abuse potential, and likelihood of causing dependence when abused.
    [Show full text]